Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaccines

Set Alert for Vaccines

Ouro Fino targets growth from greater Latin America coverage and vaccines

Brazil's Ouro Fino Saúde Animal has got a growth plan that brings internationalization and vaccines to the fore. The firm's Kleber Gomes (chief financial officer) and Ricardo Teles (business development manager) spoke about strategy to Animal Pharm correspondent Ana Andrade at the recent Animal Health Innovation Latin America conference in São Paulo.

Ouro Fino Saude Animale Vaccines

USDA to implement farm bill plans on animal health, vaccines

The USDA's Animal and Plant Health Inspection Service (APHIS) continues to work on implementing provisions in the 2018 Farm Bill dealing with animal health issues.

APHIS Policy & Regulation

BunyaVax animal health assets get boost from RVF project

Dutch start-up BunyaVax will provide its technology to a consortium developing a human Rift Valley fever (RVF) vaccine. 

R&D Vaccines

MSD adds to Bravecto, Porcilis and Bovilis ranges with European approvals

European authorities have approved MSD Animal Health's Bravecto Plus (fluralaner/moxidectin) for the treatment of ear mites in cats.

Merck MSD Animal Health Product Approvals

UK industry body determines Boehringer in breach of code on vaccine promotion

The UK's National Office of Animal Health (NOAH) has found Boehringer Ingelheim to be in breach of code on its promotion of a cattle vaccine. 

Boehringer Ingelheim Animal Health Policy & Regulation

GALVmed chief scientific officer: 'I don't think people foresaw the worldwide scale of ASF'

In light of the spread of African swine fever (ASF) in Europe and Asia, Animal Pharm editor Joseph Harvey spoke to someone who has lengthy experience in vaccine development from both a research and commercial perspective. Jeremy Salt – GALVmed's chief scientific officer – gave his viewpoint on how close the industry might be to an ASF preventative.

African swine fever Vaccines

Auburn University backs bovine respiratory disease vaccine research

A grant program at Alabama's Auburn University is funding a project focused on a respiratory disease in calves.

Bovine respiratory syndrome Vaccines

Zoetis boosts Fostera franchise in Brazil, China

Zoetis has recently gained approvals for different formulations within its Fostera swine vaccine portfolio.

Zoetis Product Approvals

Intervacc takes one step closer to European submission for horse vaccine

Swedish business Intervacc has finalized production of its vaccine for equine strangles on a commercial scale.

Vaccines Equine

Hipra boosts Asia presence with swine vaccine launch in Thailand

Laboratorios Hipra has continued its expansion across Asia with the introduction of Vepured to the Thai swine market. 

Hipra Vaccines

Elanco continues to purchase partners with $60m deal for Prevtec Microbia

Elanco has significantly bolstered its swine vaccine portfolio by acquiring Canadian company Prevtec Microbia.

Elanco Prevtec Microbia

MBFT bags option for checkpoint inhibitor and vaccine delivery tech

US start-up Man's Best Friend Therapeutics (MBFT) has enhanced development of its immunotherapeutic treatments by signing an exclusive option agreement with the University of North Carolina (UNC).

Deals R&D
See All
Advertisement
UsernamePublicRestriction

Register